Levetiracetam is a pyrrolidinone and carboxamide that is N-methylpyrrolidin-2-one in which one of the methyl hydrogens is replaced by an aminocarbonyl group, while another is replaced by an ethyl group (the S enantiomer). An anticonvulsant, it is used to treat epilepsy in both human and veterinary medicine. Among its listed roles, it functions as a anticonvulsant, an environmental contaminant and a xenobiotic. It is grouped under the following drug class(es): Neurotransmitter agents. Its therapeutic use is listed as anti-epileptic drugs, anticonvulsants and central nervous system (CNS) agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Keppra and Matever. Its PubChem CID is 5284583.
Levetiracetam
| CAS No | 102767-28-2 |
|---|---|
| Molecular Formula | C8H14N2O2 |
| Molecular Weight | 170.21 g/mol |
| Synonyms | (2S)-2-(2-oxopyrrolidin-1-yl)butanamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Levetiracetam is a pyrrolidinone and carboxamide that is N-methylpyrrolidin-2-one in which one of the methyl hydrogens is replaced by an aminocarbonyl group, while another is replaced by an ethyl group (the S enantiomer).
The listed CAS number is 102767-28-2.
The listed molecular formula is C8H14N2O2.
The listed molecular weight is 170.21 g/mol.
(2S)-2-(2-oxopyrrolidin-1-yl)butanamide.
The source lists Keppra and Matever.